Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 229

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 229
---
 certain events specified in the Underwriting Agreement.
Furthermore, pursuant to the Underwriting Agreement, the underwriters’ obligations are subject to customary conditions, representations,
and warranties, such as receipt by the underwriters of officers’ certificates and legal opinions.

The underwriters are offering
Ordinary Shares subject to prior sale when, as, and if issued to and accepted by them, subject to approval of legal matters by their counsel
and other conditions. The underwriters reserve the right to withdraw, cancel, or modify offers to the public and to reject orders in whole
or in part.

The underwriters propose to
offer the Ordinary Shares to the public at the public offering price set forth on the cover of the prospectus. After Ordinary Shares are
released for sale to the public, the underwriters may from time to time change the offering price and other selling terms.

Over-Allotment Option

We have granted to
the Representative an option, exercisable for 45 days after the closing of the offering, to purchase up to additional
Ordinary Shares (representing 15.0% of the Ordinary Shares sold in this offering) at the
initial public offering price, less the underwriting discounts and commissions. The Representative may exercise the option solely
for the purpose of covering over-allotments, if any, in connection with this offering. To the extent that the option is exercised,
each underwriter must purchase additional shares of our Ordinary Shares in an amount that is approximately proportionate to that
underwriter’s initial purchase commitment (set forth in the table above). Any shares of our Ordinary Shares issued or sold
under the option will be issued and sold on the same terms and conditions as the other shares of our Ordinary Shares that are the
subject of this offering. If this option is exercised in full, the total offering price to the public will be $12.6 million and
the total net proceeds to us, before expenses, will be $11.5 million.

<div align='center'>133</div>

Discounts and Commissions

The underwriters have advised
that the underwriters propose to offer the Ordinary Shares to the public at the public offering price per share set forth on the cover
page of this prospectus. The underwriters may offer the Ordinary Shares to securities dealers at that price less a concession of not more
than $ per share, of which up to may be re-allowed to other dealers.

The following table summarizes
the public offering price, underwriting discounts and commissions, and proceeds to